Aquatic Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-44,443
Closed -$549K 1699
2024
Q4
$549K Buy
44,443
+10,443
+31% +$120K 0.01% 694
2024
Q3
$387K Buy
34,000
+24,200
+247% +$243K 0.01% 693
2024
Q2
$70K Buy
9,800
+7,200
+277% +$55.1K ﹤0.01% 965
2024
Q1
$17.4K Buy
+2,600
New +$17.9K ﹤0.01% 1110
2023
Q3
Sell
-7,700
Closed -$108K 1734
2023
Q2
$108K Sell
7,700
-6,900
-47% -$118K 0.01% 827
2023
Q1
$274K Buy
+14,600
New +$240K 0.02% 526
2022
Q2
Sell
-300
Closed -$6K 1639
2022
Q1
$6K Buy
+300
New +$6.11K 0.01% 806

Other funds holding CDMO

Aquatic Capital Management's CDMO Position: Q1 2025 in Review

Aquatic Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 44,443 shares — an estimated $549K sold.

Aquatic Capital Management first reported a position in CDMO in Q1 2022 and held it in 7 quarters. The position peaked at $549K in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Aquatic Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 44,443 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $549K.
  • Aquatic Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Aquatic Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $549K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Aquatic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.